DE60122781D1 - Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen - Google Patents

Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen

Info

Publication number
DE60122781D1
DE60122781D1 DE60122781T DE60122781T DE60122781D1 DE 60122781 D1 DE60122781 D1 DE 60122781D1 DE 60122781 T DE60122781 T DE 60122781T DE 60122781 T DE60122781 T DE 60122781T DE 60122781 D1 DE60122781 D1 DE 60122781D1
Authority
DE
Germany
Prior art keywords
thienylcyclohexylamine
pain
derivative
treatment
therapeutic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60122781T
Other languages
English (en)
Inventor
Guy Simonnet
D Arbigny Pierre Bernard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Application granted granted Critical
Publication of DE60122781D1 publication Critical patent/DE60122781D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
DE60122781T 2000-12-20 2001-12-19 Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen Expired - Lifetime DE60122781D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0016631A FR2818147B1 (fr) 2000-12-20 2000-12-20 Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
PCT/FR2001/004050 WO2002049647A2 (fr) 2000-12-20 2001-12-19 Nouvelle application therapeutique d'un derive de la thienylcyclohexylamine

Publications (1)

Publication Number Publication Date
DE60122781D1 true DE60122781D1 (de) 2006-10-12

Family

ID=8857906

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60122781T Expired - Lifetime DE60122781D1 (de) 2000-12-20 2001-12-19 Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen

Country Status (20)

Country Link
US (2) US20050032840A1 (de)
EP (1) EP1359914B1 (de)
JP (1) JP2004525096A (de)
KR (1) KR20030070589A (de)
CN (1) CN1525860A (de)
AT (1) ATE337783T1 (de)
AU (1) AU2002225097A1 (de)
BR (1) BR0116373A (de)
CA (1) CA2432500A1 (de)
CZ (1) CZ20031727A3 (de)
DE (1) DE60122781D1 (de)
FR (1) FR2818147B1 (de)
HU (1) HUP0600063A2 (de)
IL (1) IL156144A0 (de)
MX (1) MXPA03005586A (de)
NO (1) NO20032799L (de)
PL (1) PL365913A1 (de)
RU (1) RU2003122231A (de)
WO (1) WO2002049647A2 (de)
ZA (1) ZA200305538B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2858934B1 (fr) * 2003-08-22 2006-12-29 Helene Hirbec Composition pharmaceutique et son application dans le domaine de la neurologie en tant qu'agent modulateur du systeme glutamatergique
WO2006096518A2 (en) * 2005-03-04 2006-09-14 Neurosystec Corporation Improved gacyclidine formulations
FR2946535B1 (fr) 2009-06-10 2011-09-09 Neureva Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639225B1 (fr) * 1988-11-21 1993-05-21 Centre Nat Rech Scient Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
US5972952A (en) * 1995-12-11 1999-10-26 Le Centre National De La Recherche Scientifique Neuroprotective pharmaceutical composition containing stereoisomers of arylcyclohexylamines
US6784194B2 (en) * 1996-12-06 2004-08-31 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Therapeutic use of a thienylcyclohexylamine derivative

Also Published As

Publication number Publication date
CZ20031727A3 (cs) 2004-01-14
US20090023780A1 (en) 2009-01-22
FR2818147A1 (fr) 2002-06-21
FR2818147B1 (fr) 2005-06-10
IL156144A0 (en) 2003-12-23
ZA200305538B (en) 2004-09-21
EP1359914B1 (de) 2006-08-30
NO20032799D0 (no) 2003-06-19
JP2004525096A (ja) 2004-08-19
CN1525860A (zh) 2004-09-01
EP1359914A2 (de) 2003-11-12
NO20032799L (no) 2003-08-06
AU2002225097A1 (en) 2002-07-01
HUP0600063A2 (en) 2006-11-28
ATE337783T1 (de) 2006-09-15
KR20030070589A (ko) 2003-08-30
MXPA03005586A (es) 2003-10-06
US20050032840A1 (en) 2005-02-10
BR0116373A (pt) 2004-07-06
CA2432500A1 (fr) 2002-06-27
WO2002049647A2 (fr) 2002-06-27
WO2002049647A3 (fr) 2003-09-04
PL365913A1 (en) 2005-01-10
RU2003122231A (ru) 2005-01-10

Similar Documents

Publication Publication Date Title
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
DE60043305D1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DE69805202T2 (de) Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs
DE60037394D1 (de) VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
DE60204966D1 (de) Verwendung von cyclopamine zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE60100625D1 (de) Verwndung von verbindungen mit 5-ht1a aktivität zur behandlung von krankheiten der äusseren retina
DE29602789U1 (de) Liege, Decke o.dgl. zur therapeutischen Behandlung von Lebewesen
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
PT1001775E (pt) Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
DE69916488D1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
DE60018200D1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
ATE337783T1 (de) Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
DE602004029993D1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch

Legal Events

Date Code Title Description
8332 No legal effect for de